{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Crossland PM"],"funding":["Generalitat de Catalunya","Carnegie Mellon University","Ministerio de Ciencia, Innovación y Universidades","Basic Energy Sciences","University of Minnesota","National Institutes of Health","National Institute of General Medical Sciences","NIGMS NIH HHS"],"pagination":["19608-19613"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12495302"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["16(42)"],"pubmed_abstract":["Di-iron systems that activate O<sub>2</sub> to form high-valent, oxo-bridged Fe<sup>IV</sup> <sub>2</sub> or Fe<sup>III</sup>Fe<sup>IV</sup> products are of great interest to bio-inorganic chemists due to their relevance to the chemistry of soluble methane mono-oxygenase (sMMOH), which incorporates both atoms of O<sub>2</sub> gas into a diiron(iv) complex with an Fe<sub>2</sub>O<sub>2</sub> diamond core. In this study, the [Fe<sup>III</sup> <sub>2</sub>(Me<sub>3</sub>NTB)<sub>2</sub>(μ-O)(μ-O <sub>2</sub>)]<sup>2+</sup> adduct (Me<sub>3</sub>NTB = tris((1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-2-yl)methyl)amine) reacts with two Sc<sup>3+</sup> to break the O-O bond that in turn forms the target Fe<sup>IV</sup>(μ-O)<sub>2</sub>Fe<sup>IV</sup> product. This study provides the first eviden"],"journal":["Chemical science"],"pubmed_title":["Mimicking sMMOH chemistry: trapping the Sc&lt;sup&gt;3+&lt;/sup&gt;-bound nonheme Fe&lt;sup&gt;III&lt;/sup&gt;-O-O-Fe&lt;sup&gt;III&lt;/sup&gt; adduct prior to its conversion into an Fe&lt;sup&gt;IV&lt;/sup&gt; &lt;sub&gt;2&lt;/sub&gt;(μ-O)&lt;sub&gt;2&lt;/sub&gt; core."],"pmcid":["PMC12495302"],"funding_grant_id":["P30GM133894","R01 GM-125924","PID2023-152415NB-I00","R01 GM125924","R35 GM131721","R35 GM-131721","P30 GM133894","2021SGR00487","DE-AC02-76SF00515"],"pubmed_authors":["Banerjee S","Que L","Crossland PM","Guo Y","Chandra B","Abelson CS","Swart M"],"additional_accession":[]},"is_claimable":false,"name":"Mimicking sMMOH chemistry: trapping the Sc&lt;sup&gt;3+&lt;/sup&gt;-bound nonheme Fe&lt;sup&gt;III&lt;/sup&gt;-O-O-Fe&lt;sup&gt;III&lt;/sup&gt; adduct prior to its conversion into an Fe&lt;sup&gt;IV&lt;/sup&gt; &lt;sub&gt;2&lt;/sub&gt;(μ-O)&lt;sub&gt;2&lt;/sub&gt; core.","description":"Di-iron systems that activate O<sub>2</sub> to form high-valent, oxo-bridged Fe<sup>IV</sup> <sub>2</sub> or Fe<sup>III</sup>Fe<sup>IV</sup> products are of great interest to bio-inorganic chemists due to their relevance to the chemistry of soluble methane mono-oxygenase (sMMOH), which incorporates both atoms of O<sub>2</sub> gas into a diiron(iv) complex with an Fe<sub>2</sub>O<sub>2</sub> diamond core. In this study, the [Fe<sup>III</sup> <sub>2</sub>(Me<sub>3</sub>NTB)<sub>2</sub>(μ-O)(μ-O <sub>2</sub>)]<sup>2+</sup> adduct (Me<sub>3</sub>NTB = tris((1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-2-yl)methyl)amine) reacts with two Sc<sup>3+</sup> to break the O-O bond that in turn forms the target Fe<sup>IV</sup>(μ-O)<sub>2</sub>Fe<sup>IV</sup> product. This study provides the first eviden","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Oct","modification":"2026-06-05T08:46:02.816Z","creation":"2026-05-14T03:12:30.766Z"},"accession":"S-EPMC12495302","cross_references":{"pubmed":["41050585"],"doi":["10.1039/d5sc05667e"]}}